Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Neoleukin Therapeutics, Inc.
Scientific Title
A First-in-Human Phase 1 Study of NL-201 in Patients With Relapsed or Refractory Cancer